Here, we evaluated PTX3 tissue expression and serum levels as biomarkers of clear cell renal cell carcinoma (ccRCC) and analyzed the possible role of complement system activation on tumor site. The gene discussed is PTX3; the disease is nonpapillary renal cell carcinoma.